These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3118788

  • 21. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
    Ionescu A, Meitert E, Vasiliu S, Meitert T, Milicescu S, Sima F, Savulian C.
    Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594
    [No Abstract] [Full Text] [Related]

  • 22. Vaccines against Pseudomonas aeruginosa infection: 2. Clinico-immunological investigations.
    Krokhina MA, Grishina IA, Panova YuM, Terekhova RP, Severtsova MK, Yedvabnaya LS, Vaide M, Varro R, Rusanov VM, Kolker II.
    Vaccine; 1985 Sep; 3(3):316-24. PubMed ID: 3933202
    [Abstract] [Full Text] [Related]

  • 23. Prophylactic and therapeutic protection of human IgG purified from sera containing anti-exotoxin A titers against pneumonia caused by Pseudomonas aeruginosa.
    Zhang J, Wan C, Yu B, Gao C, Zhao L, Cheng X, Yang F, Gu H, Zou Q, Gu J, Wang X.
    Hum Vaccin Immunother; 2019 Sep; 15(12):2993-3002. PubMed ID: 31116632
    [Abstract] [Full Text] [Related]

  • 24. Therapy of established experimental Pseudomonas aeruginosa infections with oral ciprofloxacin and five human monoclonal antibodies against lipopolysaccharide antigens.
    Collins MS, Ladehoff D, Mehton NS.
    Antibiot Chemother (1971); 1991 Sep; 44():185-95. PubMed ID: 1801636
    [No Abstract] [Full Text] [Related]

  • 25. Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa infection in a murine burn wound model.
    Felts AG, Giridhar G, Grainger DW, Slunt JB.
    Burns; 1999 Aug; 25(5):415-23. PubMed ID: 10439150
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparative anti-Pseudomonas aeruginosa activity of chemically modified and native immunoglobulin G (human), and potentiation of antibiotic protection against Pseudomonas aeruginosa and group B Streptococcus in vivo.
    Collins MS, Dorsey JH.
    Am J Med; 1984 Mar 30; 76(3A):155-60. PubMed ID: 6424444
    [Abstract] [Full Text] [Related]

  • 28. [Prevention using a Pseudomonas immunoglobulin in burn patients].
    Stuttmann R, Petrovici V, Hartert M.
    Infection; 1987 Mar 30; 15(1):80-4. PubMed ID: 3106234
    [Abstract] [Full Text] [Related]

  • 29. Feasibility of prophylaxis and therapy against gram-negative infections by human monoclonal antibodies.
    Lang AB, Fürer E, Cryz SJ.
    FEMS Immunol Med Microbiol; 1993 Jun 30; 7(1):9-13. PubMed ID: 8364527
    [Abstract] [Full Text] [Related]

  • 30. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
    Lang AB, Fürer E, Senyk G, Larrick JW, Cryz SJ.
    Hum Antibodies Hybridomas; 1990 Jun 30; 1(2):96-103. PubMed ID: 2129420
    [Abstract] [Full Text] [Related]

  • 31. [Donor plasma with anti-Pseudomonas aeruginosa activity as a directed-action preparation].
    Nazarchuk LV.
    Vrach Delo; 1987 Jul 30; (7):96-8. PubMed ID: 3114958
    [No Abstract] [Full Text] [Related]

  • 32. The pathogenesis of infections owing to Pseudomonas aeruginosa using the burned mouse model: experimental studies from the Shriners Burns Institute, Cincinnati.
    Holder IA.
    Can J Microbiol; 1985 Apr 30; 31(4):393-402. PubMed ID: 3924388
    [No Abstract] [Full Text] [Related]

  • 33. Immunotherapy with IgY Antibodies toward Outer Membrane Protein F Protects Burned Mice against Pseudomonas aeruginosa Infection.
    Norouzi F, Behrouz B, Ranjbar M, Mousavi Gargari SL.
    J Immunol Res; 2020 Apr 30; 2020():7840631. PubMed ID: 32566689
    [Abstract] [Full Text] [Related]

  • 34. [Development of immunological preparations and their use for preventing and treating pyocyanic infection in burn patients].
    Kolker II, Stanislavskiĭ ES, Grishina IA, Panova IuM, Krokhina MA.
    Probl Gematol Pereliv Krovi; 1981 Jan 30; 26(1):29-33. PubMed ID: 6784114
    [No Abstract] [Full Text] [Related]

  • 35. [Polish preparations for preventing and treating infections caused by Pseudomonas aeruginosa].
    Schiller B, Buchowicz I, Lysakowska E, Sakiel S, Korbecki M.
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr 30; (4):30-2. PubMed ID: 2409720
    [Abstract] [Full Text] [Related]

  • 36. Immunization of burned patients against Pseudomonas aeruginosa infection at Safdarjang Hospital, New Delhi.
    Roe EA, Jones RJ.
    Rev Infect Dis; 1983 Apr 30; 5 Suppl 5():S922-30. PubMed ID: 6419315
    [Abstract] [Full Text] [Related]

  • 37. The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.
    Kinoshita M, Kato H, Yasumoto H, Shimizu M, Hamaoka S, Naito Y, Akiyama K, Moriyama K, Sawa T.
    Hum Vaccin Immunother; 2016 Nov 30; 12(11):2833-2846. PubMed ID: 27454613
    [Abstract] [Full Text] [Related]

  • 38. [Dynamics of the contamination of mice during the treatment of burn sepsis due to Pseudomonas aeruginosa using tobramycin alone or combined with active and passive immunization].
    Minukhin VV, Tsyganenko AIa.
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Sep 30; (9):90-2. PubMed ID: 3098009
    [Abstract] [Full Text] [Related]

  • 39. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.
    Hemachandra S, Kamboj K, Copfer J, Pier G, Green LL, Schreiber JR.
    Infect Immun; 2001 Apr 30; 69(4):2223-9. PubMed ID: 11254577
    [Abstract] [Full Text] [Related]

  • 40. A clinical trial of i.v. tetravalent hyperimmune Pseudomonas globulin G in burned patients.
    Hunt JL, Purdue GF.
    J Trauma; 1988 Feb 30; 28(2):146-51. PubMed ID: 3126302
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.